Biote Corp. Files 8-K on Financials and Exit Costs
Ticker: BTMD · Form: 8-K · Filed: May 7, 2025 · CIK: 1819253
Sentiment: neutral
Topics: financial-condition, exit-costs, company-name-change
TL;DR
Biote Corp. 8-K: Financials updated, exit costs detailed. Formerly Haymaker Acquisition Corp. III.
AI Summary
Biote Corp. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition as of May 1, 2025. The filing also details costs associated with exit or disposal activities and includes financial statements and exhibits. Biote Corp. was formerly known as Haymaker Acquisition Corp. III.
Why It Matters
This filing provides investors with crucial updates on Biote Corp.'s financial performance and any restructuring or disposal activities, impacting the company's valuation and future outlook.
Risk Assessment
Risk Level: medium — The filing concerns financial results and potential exit costs, which can indicate operational challenges or strategic shifts that may affect the company's stability.
Key Players & Entities
- biote Corp. (company) — Registrant
- Haymaker Acquisition Corp. III (company) — Former company name
- May 01, 2025 (date) — Earliest event reported
- May 7, 2025 (date) — Date of report
FAQ
What are the specific results of operations and financial conditions reported by Biote Corp. as of May 1, 2025?
The 8-K filing indicates that Biote Corp. is reporting on its results of operations and financial condition as of May 1, 2025, but the specific details are contained within the referenced financial statements and exhibits.
What costs associated with exit or disposal activities are detailed in this filing?
The filing explicitly mentions 'Cost Associated with Exit or Disposal Activities' as an item of information, with the specifics to be found in the accompanying exhibits and financial statements.
When did Biote Corp. change its name from Haymaker Acquisition Corp. III?
The filing states the date of the name change from Haymaker Acquisition Corp. III to biote Corp. was July 27, 2020.
What is the principal executive office address for Biote Corp.?
The principal executive offices of Biote Corp. are located at 1875 W. Walnut Hill Ln #100, Irving, Texas 75038.
What is the SIC code for Biote Corp.?
The Standard Industrial Classification (SIC) code for Biote Corp. is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding biote Corp. (BTMD).